Skip to main content

LSE is open and running as normal following Microsoft global worldwide outage

The Microsoft outage is impacting global systems. At LSE, this may be affecting daily tools that staff and students use such as email, Copilot, Excel and others. Staff can use Teams to contact others. LSE is open and running as normal, but responses to queries maybe slower than usual today. For staff and students, updates will be available on LSE’s DTS Service Portal

- check for the latest information.

Mapping Chronic Non-Communicable Diseases (MAPPING_NCD)

Primary Investigator: Panos Kanavos
Project Coodinator: Hala Hourani
Start Date: 01 Janaury 2014
End Date: 31 December 2015
Region: Europe
Keywords: chronic non-communicable diseases, cardiovascular disease, chronic respiratory diseases, diabetes, cancer, mental health, European Union, mapping, health policy, health technology regulation & assessment

MAPPING_NCD mapped European Union member state activity, investment and initiatives to combat NCDs, describing and quantifying their impact in five key disease areas: cardiovascular disease, chronic respiratory diseases, diabetes, cancer and mental health. More specifically, the project had six distinct objectives:

  • Identify current EU-funded, as well as national, regional and charitable research programmes and initiatives in the field of chronic non-communicable diseases.
  • Map the scale and scope of research activities in this area, including the research fields addressed and their implementation modalities.
  • Provide adequate comparison of data and results through the use of common definition criteria and methodology.
  • Analyse their funding sources and map the impact of overall investments and outputs to date.
  • Identify potential overlaps, synergies, gaps and opportunities for future collaboration.
  • Contribute to the development of evidence-based policies towards supporting coordinated approaches in chronic non-communicable diseases research.

Outcomes

See more information on project findings and outcomes.